Canal Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,753
Closed -$915K 147
2021
Q4
$915K Sell
11,753
-1,898
-14% -$168K 0.22% 75
2021
Q3
$1.3M Buy
13,651
+1,399
+11% +$148K 0.37% 64
2021
Q2
$1.52M Buy
12,252
+1,321
+12% +$158K 0.44% 61
2021
Q1
$1.44M Buy
10,931
+312
+3% +$42.7K 0.49% 63
2020
Q4
$1.41M Sell
10,619
-180
-2% -$21.8K 0.53% 58
2020
Q3
$1.1M Buy
+10,799
New +$933K 0.48% 64

Other funds holding EXAS

Canal Capital Management's EXAS Position: Q1 2022 in Review

Canal Capital Management sold out of Exact Sciences (EXAS) in Q1 2022, closing a stake of 11,753 shares — an estimated $915K sold.

Canal Capital Management first reported a position in EXAS in Q3 2020 and held it in 6 quarters. The position peaked at $1.52M in Q2 2021. 559 funds tracked by Wall St. Rank hold EXAS as of Q1 2022.

  • Canal Capital Management reported no remaining Exact Sciences position as of Q1 2022 after selling out during the quarter.
  • Canal Capital Management sold 11,753 Exact Sciences shares in Q1 2022, an estimated $915K.
  • Canal Capital Management first reported a position in Exact Sciences in Q3 2020 and held it in 6 quarters.
  • Canal Capital Management's Exact Sciences position peaked at $1.52M in Q2 2021.
  • 559 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2022.

Based on Canal Capital Management's 13F filing for Q1 2022, filed 20 Apr 2022.